Protocol Ledger

NCT07116733 · Phase III · RECRUITING

Desflurane vs. Propofol for Cardiac Anesthesia

Interventional Phase III clinical trial protocol NCT07116733 sponsored by Xijing Hospital in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-10-20 Enrollment: 3,560 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07116733
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)3,560 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07116733
Protocol FieldVerified Registry Value
NCT IdentifierNCT07116733
Consolidated Lead SponsorXijing Hospital
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment3,560 participants (ESTIMATED)
Registered Start Date2025-10-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07116733
Hospital Research SiteLocationSite Profile
The First Hospital of Hebei Medical UniversityShijiazhuang, ChinaOpen Hospital Dossier ->
The first affiliated hospital of Zhengzhou UniversityZhengzhou, ChinaOpen Hospital Dossier ->
Sichuan Provincial People's HospitalChengdu, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI